Resources > Value Pharming
Value Pharming
Marjorie Corman Aaron
This is a two party case, to be negotiated between counsel for Next- Pharm, a joint venture between the State University Bio-Medical Research Department and Pharmalux, a pharmaceutical company. At the time the joint venture began, Pharmalux could have been accurately characterized as “small and young but a promising company”. Since then, Pharmalux has done quite well. The Next-Pharm’s advisory board included representatives of Pharmalux and the University and of the city and state’s business development offices. It draws on the expertise of State University’s bio-medical graduate students and professors for research design, implementation, and product development. Next-Pharm owns the intellectual property. Proceeds from selling or licensing the intellectual property are distributed back to State University and Pharmalux, after setting aside funds needed for research projects. Drug and drug delivery systems developed and designed are produced, marketed, and sold exclusively by Pharmalux.
Value Pharming Negotiation – Teaching Note (pdf)
Value Pharming Negotiation – General and Confidential Information for Next-Pharm Attorney (pdf)
Value Pharming Negotiation – General and Confidential Information for Pure Health Attorney (pdf)